Royalty Pharma plc (RPRX) NASDAQ
49.43
-0.11(-0.22%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
49.43
-0.11(-0.22%)
Currency In USD
| Market Cap | 16.69B |
| Enterprise Value | 25.02B |
| P/E Ratio | 27.69 |
| PEG Ratio | 26.72 |
| Price/Sales Ratio | 8.9 |
| Price/Book Ratio | 3.3 |
| Enterprise/Revenue | 12.41 |
| Enterprise/EBITDA | 18.06 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.32 |
| Operating Margin | 0.66 |
| Return On Assets | 0.04 |
| Return On Equity | 0.12 |
| Revenue | 2.38B |
| Revenue/Share | 5.51 |
| Gross Profit | 2.38B |
| EBITDA | 1.64B |
| Net Income | 770.95M |
| Diluted EPS | 1.8 |
| Total Cash | 637.5M |
| Total Cash/Share | 1.48 |
| Total Debt | 8.95B |
| Total Debt/Equity | 1.38 |
| Current Ratio | 0.97 |
| Book Value Per Share | 22.49 |
| 52-Week Change | 51.12 |
| 52-Week High | 50.25 |
| 52-Week Low | 31.97 |
| Moving Average 50 Days | 47.07 |
| Moving Average 200 Days | 40.34 |
| Average Volume | 3.41M |
| Shares Outstanding | 428.42M |
| % Held by Institutions | 83.03 |
| Trailing Annual Dividend Rate | 0.89 |
| Trailing Annual Dividend Yield | 1.81 |
| Payout Ratio | 0.49 |
| Last Split Factor | N/A |
| Last Split Date | N/A |